NCT02806713View on ClinicalTrials.gov

The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study)

PHASE3CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

August 31, 2017

Study Completion Date

August 31, 2017

Conditions
Dysfunctional VoidingPostoperative Pain
Interventions
DRUG

Phenazopyridine

OTHER

no Phenazopyridine

Because the obvious effects on the urine coloration of pyridium no placebo or dummy are provided

Trial Locations (1)

01605

Umass Memorial, Worcester

All Listed Sponsors
lead

University of Massachusetts, Worcester

OTHER

NCT02806713 - The Effect of Oral PhenazopyrIdine on Perioperative Voiding After Mid-urethral sliNg (EPIPhANy Study) | Biotech Hunter | Biotech Hunter